Pharmacosmos   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Holbaek Denmark (1965)
Status: No NME R&D (1965)

Organization Overview

First Clinical Trial
2007
NCT00536666
First Marketed Drug
2020
iron isomaltoside
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pharmacosmos A/S | PHARMACOSMOS AS | Pharmacosmos A/S, Roervangsvej 30, DK 4300 Holbaek, Denemark | Pharmacosmos UK Ltd